Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion
Thyme Care secures a $125 million Series E round, elevating its valuation past $2 billion.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 4.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
Source diversity sample: Nashville Post · Dealroom · Pulse 2.0 · MedCity News · Fierce Healthcare · CNBC.
How this dossier is built: methodology · AI policy · corrections.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Where it stands
Oncology company Thyme Care has raised $125 million in a Series E funding round, pushing its valuation above $2 billion. Financial backing for the round comes from investors including Morgan Health, Humana, and CVS Health Ventures, according to reports from Fierce Healthcare and CNBC.
Alongside the funding, the startup has launched a new oncology parent entity and holding company named Thyme Companies, as detailed by Dealroom, Pulse 2.0, and MedCity News. Coverage does not yet specify how the newly acquired capital will be allocated or what specific operational changes will follow the creation of the parent entity.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
The reporting (6)
- Thyme Care announces $125M Series E round Nashville Post · 21h ago
- Thyme Care raises $125M Series E at $2B valuation, launches oncology holding company Dealroom · 21h ago
- Thyme Care Raises Over $125 Million Series E At More Than $2 Billion Valuation And Launches Thyme Companies Pulse 2.0 · 21h ago
- Thyme Care Raises $125M, Launches New Oncology Parent Entity MedCity News · 21h ago
- Oncology company Thyme Care raises $125M, backed by Morgan Health, Humana and CVS Health Ventures Fierce Healthcare · 21h ago
- Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion CNBC · 21h ago
Answered
How much did Thyme Care raise?
Thyme Care raised $125 million in a Series E round.
What is Thyme Care's valuation?
The funding round pushed the startup's valuation above $2 billion.
What new entity was launched?
The company launched a new oncology parent entity and holding company called Thyme Companies.
Topics
From around our network
Related trends
UnitedHealthcare to drop prior authorization requirements for range of conditions from Oct. 1
UnitedHealthcare moves to drop prior authorization requirements for 1,700 codes while drawing a mixed reaction from observers.
AI giants lean into health care to stall public backlash
AI giants pivot into health‑care to cushion backlash, igniting questions about the depth of upcoming AI integration
Medtronic Lifts Outlook, Invests Over $700 Million in Heart Tech & Robotics
Medtronic's strategic investments in heart technology and robotics are driving its fiscal outlook upward.
Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson
Hackers claim to have stolen 284 million patient records from McKesson, a healthcare giant that supplies one in three hospital prescriptions.
‘Superhuman’ AI tool spots heart disease in less than 2 seconds
A new AI reads ECGs in under two seconds, promising instant heart‑disease alerts as the NHS rolls it out.
Column | I’m an oncologist. Every man should know this about prostate cancer.
September is Prostate Cancer Awareness Month, and oncologists are urging men to get screened.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.